ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,454,705 | -12.4% | 90,446 | -0.8% | 0.00% | -100.0% |
| Q2 2023 | $2,803,304 | +48.9% | 91,194 | +74.5% | 0.00% | – |
| Q1 2023 | $1,882,567 | -98.6% | 52,250 | -98.5% | 0.00% | -100.0% |
| Q4 2022 | $134,009,199 | -15.6% | 3,390,921 | -14.2% | 0.03% | -20.6% |
| Q3 2022 | $158,756,000 | +12.2% | 3,951,117 | +17.4% | 0.03% | +21.4% |
| Q2 2022 | $141,447,000 | +17.1% | 3,364,603 | +8.5% | 0.03% | +33.3% |
| Q1 2022 | $120,769,000 | -2.4% | 3,099,830 | -0.2% | 0.02% | +5.0% |
| Q4 2021 | $123,747,000 | +9.5% | 3,105,308 | -0.7% | 0.02% | +5.3% |
| Q3 2021 | $113,061,000 | -35.9% | 3,128,405 | -27.3% | 0.02% | -34.5% |
| Q2 2021 | $176,402,000 | -17.4% | 4,303,526 | -12.0% | 0.03% | -23.7% |
| Q1 2021 | $213,436,000 | -27.3% | 4,893,133 | -16.6% | 0.04% | -29.6% |
| Q4 2020 | $293,741,000 | +22.5% | 5,868,929 | +3.0% | 0.05% | +8.0% |
| Q3 2020 | $239,804,000 | -11.9% | 5,700,113 | +1.7% | 0.05% | -18.0% |
| Q2 2020 | $272,148,000 | – | 5,605,531 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |